tirzepatide for weight loss without diabetes Medscape Tirzepatide For Weight Loss In

GPX4, Glutathione Peroxidase 4

Tirzepatide shows greater weight loss (16 to 22.5% of body weight) compared to orforglipron (12.4% at a 36 mg dose)

This is in line with studies showing that GLP-1 increases vascular blood flow and activates glucose delivery into skeletal muscle via AMP-activated protein kinase (AMPK), thereby promoting muscle synthesis, reducing muscle breakdown (50, 51) and improving muscle microvascular recruitment (MVR) through increased endothelial surface area (52)

Her approach is grounded in science and shaped by a strong understanding of personalised nutrition and the human microbiome

Additionally, Mohiuddin et al (165) indicated that GLP-1RAs exerted neuroprotective effects through direct action on root ganglion neurons